drugset / Trial / NCT04426422

Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes

NCT04426422 ↗

Phase 4 Completed 52 enrolled Shenzhen People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study was aimed to investigate the effect of metformin on the gut microbiota and glycemic control in newly diagnosed type 2 diabetes patients.

Timeline

Start
2017-03-01
Primary completion
2018-06-30
Completion
2018-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1500 mg —
Subject Metformin Small molecule 2000 mg —